Cargando…
Evaluating the bioequivalence of two pitavastatin calcium formulations based on IVIVC modeling and clinical study
In vitro‐in vivo correlation (IVIVC) allows prediction of the in vivo performance of a pharmaceutical product based on its in vitro drug release profiles and can be used to reduce the number of bioequivalence (BE) studies during product development, and facilitate certain regulatory decisions. Here,...
Autores principales: | Wang, Jiaying, Chen, Jinliang, Wang, Lu, Yang, Dandan, Shao, Rong, Lou, Honggang, Ruan, Zourong, Jiang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841298/ https://www.ncbi.nlm.nih.gov/pubmed/36178248 http://dx.doi.org/10.1111/cts.13426 |
Ejemplares similares
-
Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations
por: Wang, Lu, et al.
Publicado: (2023) -
In silico prediction of bioequivalence of atorvastatin tablets based on GastroPlus™ software
por: Wang, Lu, et al.
Publicado: (2023) -
In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone
por: Tosca, Elena M., et al.
Publicado: (2021) -
First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model
por: Chen, Jinliang, et al.
Publicado: (2022) -
Development of a particle swarm optimization-backpropagation artificial neural network model and effects of age and gender on pharmacokinetics study of omeprazole enteric-coated tablets in Chinese population
por: Xu, Yichao, et al.
Publicado: (2022)